查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750794

數位病理學市場規模、佔有率、趨勢分析報告：按產品、類型、應用、最終用途、地區、細分市場預測，2025-2030 年

Digital Pathology Market Size, Share & Trends Analysis Report By Product (Software, Device), By Type, By Application (Academic Research, Disease Diagnosis), By End Use (Diagnostic Labs, Hospitals), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 185 Pages | 商品交期: 2-10個工作天內

價格

數位病理學市場的成長和趨勢：

根據 Grand View Research, Inc. 的一份新報告，預計到 2030 年全球數位病理學市場規模將達到 17.4 億美元。

預計2025年至2030年期間，該市場的複合年成長率將達到8.2%。由於慢性病盛行率的上升以及對精準診斷的需求不斷成長，預計市場將呈指數級成長。慢性病影響近三分之一的美國成年人。根據美國疾病管制與預防中心的數據，約51.8%的美國成年人至少患有一種慢性病。數位病理學涵蓋分子組織分析、生物樣本庫、組織微陣列分析和分子生物學，在藥物開發平臺和伴隨診斷中發揮關鍵作用。組織生物標記研究中對高品質組織樣本的需求不斷成長，預計將在預測期內推動該技術的普及。

隨著遠端病理學技術的不斷更新，其應用範圍正在不斷擴大。例如，Tribun Health 於 2022 年 6 月推出了 TeleSlide Patho 5，這是一個線上遠距病理學平台，用於為患者提供臨床和及時的專業知識。此外，隨著各公司採取更嚴格的競爭策略，預計在不久的將來，遠距病理學市場將面臨激烈的競爭。此外，病理實驗室數位化等技術進步正在提高該專業的效率，提高檢體的可重複性，並減輕病理學家的工作負擔。過去幾年，多項突破性進展顯著推動了市場的成長。

例如，2021年9月，Paige的前列腺癌檢測人工智慧解決方案Paige Prostate獲得FDA核准，這是第一個獲得上市核准的人工智慧病理學產品。 2021年10月，羅氏公司（F. Hoffmann-La Roche Ltd.）與Ibex合作開發基於人工智慧的病理學應用程式，旨在改善患者照護。此外，主要企業正在採取合作與夥伴關係等策略，重點關注機器人光學顯微鏡、數影像處理、多光纖通訊和電腦化等技術進步，以加強數位病理學的普及。

例如，Deciphex 於 2022 年 12 月推出了 Patholytix 3.0，這是一個數位研究病理學平台，旨在徹底改變病理學家可用的工具，並克服 LIMS 軟體的局限性，使用戶能夠有效地管理相關數據和樣本。此外，該公司還宣布了新平台的一些功能，這些功能將影響工作流程，並使報告更簡單、更快捷。

數位病理市場報告重點

  • 按產品分類，預計到2024年，設備細分市場將佔據最大佔有率，達到51.50%，並預計在預測期內將保持可觀的成長率。設備細分市場包括切片管理系統和掃描器。該細分市場的成長可歸因於數位病理學在學術研究活動中的日益普及，其解析度也得到了提升。
  • 從應用角度來看，由於慢性病盛行率上升和對先進診斷技術的需求不斷增加，疾病診斷預計將在 2025 年至 2030 年間實現最快的成長率。
  • 根據最終用途，由於醫療保健環境中擴大採用數位病理診斷來實現高效的疾病診斷，醫院部門將在 2024 年佔據市場主導地位，佔有 36.7% 的佔有率。
  • 由於擁有完善的數位基礎設施以及醫療保健環境中採用技術的多項技術進步，北美在 2024 年佔據了整個市場的 40.10% 的佔有率。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章數字病理學市場變數、趨勢和範圍

  • 數位病理市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 產業挑戰
    • 機會分析
  • 數位病理學市場分析工具：波特五力分析
  • SWOT分析：依因素（政治/法律、經濟、社會、科技）
    • 科技趨勢分析
  • 法律規範
    • 對新參與者的監管要求
    • 政治局勢、當前情勢和未來情勢
  • 成本結構分析
    • 實施成本
    • 價格下降分析
  • 使用者觀點分析
    • 消費行為分析
  • 案例研究
  • COVID-19的影響
    • 打入市場策略

第4章數位病理學市場：產品估計與趨勢分析

  • 數位病理學市場：產品亮點
  • 數位病理市場：產品趨勢分析
  • 軟體
  • 裝置
    • 掃描器
    • 幻燈片管理系統
  • 儲存系統

第5章數位病理學市場：應用評估與趨勢分析

  • 數位病理市場：關鍵應用點
  • 數位病理市場：應用變化分析
  • 藥物研發
  • 學術研究
  • 疾病診斷
    • 癌細胞檢測
    • 其他

第6章數字病理學市場：類型估計和趨勢分析

  • 數位病理市場：類型要點
  • 數位病理學市場：類型變化分析
  • 人體病理學
  • 獸醫病理學

第7章數字病理學市場：最終用途估計和趨勢分析

  • 數位病理學市場：關鍵最終用途點
  • 數位病理學市場：最終用途趨勢分析
  • 醫院
  • 生物技術和製藥公司
  • 診斷實驗室
  • 學術和研究機構

第 8 章數位病理學市場：區域估計和趨勢分析（按產品、應用和最終用途）

  • 數位病理學市場：區域趨勢分析
  • 2023 年及 2030 年各地區數位病理學市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 荷蘭
    • 瑞士
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 印尼
    • 泰國
    • 澳洲
    • 韓國
    • 菲律賓
    • 馬來西亞
    • 新加坡
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 土耳其
    • 伊朗
    • 阿拉伯聯合大公國
    • 以色列
    • 科威特

第9章數位病理學市場競爭與供應商格局

  • 參與類別
  • 供應商格局
    • 經銷商名單
  • 企業市場分析
    • 上市公司
    • 私人公司
  • 2024年公司市場佔有率評估分析（%）
  • 公司簡介
    • Leica Biosystems Nussloch Gmbh (Danaher)
    • HAMAMATSU PHOTONICS KK
    • KONINKLIJKE PHILIPS NV
    • OLYMPUS CORPORATION
    • MIKROSCAN TECHNOLOGIES, INC.
    • INSPIRATA, INC.
    • VISIOPHARM A/S
    • HURON TECHNOLOGIES INTERNATIONAL, INC.
    • 3DHISTECH LTD.
    • CONTEXTVISION AB
    • SECTRA AB
    • AGFA-GEVAERT GROUP
    • 細胞視覺
    • HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
    • WEST MEDICA PRODUKTIONS- UND HANDELS- GMBH (WEST MEDICA)
    • AETHERAI
    • IBEX (IBEX MEDICAL ANALYTICS)
    • SIGTUPLE TECHNOLOGIES PRIVATE LIMITED
    • MORPHLE LABS, INC
    • BIONOVATION BIOTECH, INC
    • SCOPIO LABS
    • PATH HUB US
    • F. HOFFMANN-LA ROCHE LTD.
    • Aiosyn
    • Proscia Inc
    • EVIDENT
    • Aignostics, Inc.
    • AIRA MATRIX
    • Deep Bio Inc.
    • Indica Labs, LLC
    • Paige AI
    • PathAI, Inc.
    • Aiforia
    • Dedalus SpA
    • Qritive
    • Mindpeak GmbH
    • CGI Inc.
    • Gestalt
    • Epredia (3DHISTECH Ltd.)
Product Code: 978-1-68038-386-7

Digital Pathology Market Growth & Trends:

The global digital pathology market size is anticipated to reach USD 1.74 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.2% from 2025 to 2030. The market is anticipated to witness exponential growth owing to rising prevalence of chronic diseases aided by increasing demand for accurate diagnostics. Chronic diseases affect nearly one in every three adults. Whereas, according to the CDC, in the U.S., approximately, 51.8% of adults have at least one chronic disease. Digital pathology, including molecular tissue profiling, biobanking, tissue microarray analysis, and molecular biology, plays an important role in the drug development pipeline and companion diagnostics. Growing demand for high-quality tissue samples in tissue-based biomarker research is expected to drive technology adoption over the forecast period.

Increasing adoption of telepathology with the launch of newer versions of the technology, such as in June 2022, Tribun Health launched TeleSlide Patho 5, an online telepathology platform used for providing clinical and timely expertise to patients. Moreover, the market is expected to see intense competition in the near future as companies adopt more stringent strategies to compete. Moreover, technological advancements, such as the digitization of pathology lab makes the specialty more efficient, the specimen more reproducible, and pathologists' work easier. In past few years, several breakthrough advancements have provided a significant boost to market growth.

For instance, in September 2021, Paige received FDA approval for Paige Prostate, an AI solution for the detection of prostate cancer. The product is the first AI-enabled pathology product to gain marketing authorization. This was further followed by the collaboration of F. Hoffmann-La Roche Ltd. with Ibex in October 2021 for the development of artificial intelligence-based pathology applications for the improvement of patient care. Furthermore, major players are adopting strategies like collaborations and partnerships with a focus on technological advancements, such as robotic light microscopy, digital imaging, multiple fiber optic communications, and computerization, to enhance the adoption of digital pathology.

For instance, in December 2022, Deciphex launched Patholytix 3.0, a Digital Research Pathology Platform with an aim to revolutionize tools available for research pathologists and designed to overcome the limits of LIMS software that allows users to effectively manage associated data and samples. Furthermore, with the launch, the company also highlighted features of the new platform that impact workflow and offer simpler and more expedient report creation.

Digital Pathology Market Report Highlights:

  • Based on product, The device segment held the largest share of 51.50% in 2024 and is anticipated to grow at a lucrative growth rate during the projected period. The device segment includes a slide management system and scanner. The segment growth is attributed to the increasing adoption of digital pathology in academic research activities with enhanced resolution
  • Based on application, Disease diagnosis is anticipated to witness the fastest growth rate from 2025 to 2030 due to an increasing prevalence of chronic diseases and demand for noble diagnosis techniques
  • In terms of end-use, The hospitals segment dominated the market in 2024 with a share of 36.7% due to the growing incorporation of digital pathologies in healthcare settings for efficient disease diagnosis
  • North America dominated overall market in 2024 with a share of 40.10%, due to the presence of well-established digital infrastructure and several technological advancements pertaining to the incorporation of technology in healthcare settings

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
  • 1.4 Model Details
    • 1.4.1 Commodity Workflow Analysis (Model 1)
    • 1.4.2 Volume Price Analysis (Model 2)
    • 1.4.3 Market Survey Research Methodology
      • 1.4.3.1 General Methodology
    • 1.4.4 Country Level Assumptions
    • 1.4.5 Subsegment Level Assumptions
  • 1.5 List of Primary Sources
  • 1.6 List of Secondary Sources
  • 1.7 List of Abbreviations
  • 1.8 Market Definitions
  • 1.9 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Digital Pathology Market Snapshot
    • 2.1.1 Digital Pathology Market Snapshot: Type & Product Segment Outlook
    • 2.1.2 Digital Pathology Market Snapshot: Application & End Use Segment Outlook
    • 2.1.3 Digital Pathology Market Snapshot: Competitive Outlook

Chapter 3 Digital Pathology Market Variables, Trends and Scope

  • 3.1 Digital Pathology Market Dynamics
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Increasing prevalence of chronic diseases
      • 3.1.1.2 Higher cost-efficiency
      • 3.1.1.3 Rapid technological advancements in the overall digital pathology market
        • 3.1.1.3.1 Competitive Factors and Strategies
          • 3.1.1.3.1.1 List of Top Notable Funded Digital Pathology Companies, By Countries
          • 3.1.1.3.1.2 Top 10 Vendor - by Total Funding from 2014 - 2021 (Potential vendors for collabrations)
      • 3.1.1.4 Increasing demand for integrated healthcare systems and patient-centric care-
      • 3.1.1.5 Growing adoption of digital pathology solutions in veterinary care practices
      • 3.1.1.6 Rapid technological advancements in digital pathology solutions in veterinary field
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 Lack of skilled professionals
      • 3.1.2.2 High cost of implementing digital pathology solutions
        • 3.1.2.2.1 Digital Pathology Expenses
    • 3.1.3 Industry Challenges
      • 3.1.3.1 Lack of reimbursement for digital pathology-enabled services
      • 3.1.3.2 Data security and privacy
    • 3.1.4 Opportunity Analysis
      • 3.1.4.1 Potential growth for digital pathology solutions
  • 3.2 Digital Pathology Market Analysis Tools: Porters
  • 3.3 SWOT Analysis by Factors (Political & Legal, Economic, Social, and Technology)
    • 3.3.1 Technology Trend Analysis
      • 3.3.1.1 Digitization in Pathology Labs
  • 3.4 Regulatory Framework
    • 3.4.1 Regulatory Requirements For New Players
      • 3.4.1.1 Food and Drug Administration (FDA)
      • 3.4.1.2 Centers for Medicare and Medicaid Services (CMS)/Clinical Laboratory Improvement Amendments (CLIA)
      • 3.4.1.3 College of American Pathologists (CAP)
    • 3.4.2 Political Landscape, Current & Future Scenario
  • 3.5 Cost Structure Analysis
    • 3.5.1 Cost Of Implementation
      • 3.5.1.1 Secondary Research Analysis on digital pathology operational costs
    • 3.5.2 Price Erosion Analysis
  • 3.6 User Perspective Analysis
    • 3.6.1 Consumer Behaviour Analysis
      • 3.6.1.1 Consumer Preference
  • 3.7 Case Study
  • 3.8 Covid-19 Impact
    • 3.8.1 Market Entry Strategies
      • 3.8.1.1 Competitive Strategies

Chapter 4 Digital Pathology Market: Product Estimates & Trend Analysis

  • 4.1 Digital Pathology Market: Product Key Takeaways
  • 4.2 Digital Pathology Market: Product Movement Analysis
  • 4.3 Software
    • 4.3.1 Software Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.4 Device
    • 4.4.1 Device Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.2 Scanners
      • 4.4.2.1 Scanners Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 4.4.3 Slide Management System
      • 4.4.3.1 Slide Management System Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 4.5 Storage System
    • 4.5.1 Storage System Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 5 Digital Pathology Market: Application Estimates & Trend Analysis

  • 5.1 Digital Pathology Market: Application Key Takeaways
  • 5.2 Digital Pathology Market: Application Movement Analysis
  • 5.3 Drug Discovery & Development
    • 5.3.1 Drug Discovery & Development Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.4 Academic Research
    • 5.4.1 Academic Research Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 5.5 Disease Diagnosis
    • 5.5.1 Disease Diagnosis Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.2 Cancer Cell Detection
      • 5.5.2.1 Cancer Cell Detection Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 5.5.3 Others
      • 5.5.3.1 Others market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 6 Digital Pathology Market: Type Estimates & Trend Analysis

  • 6.1 Digital Pathology Market: Type Key Takeaways
  • 6.2 Digital Pathology Market: Type Movement Analysis
  • 6.3 Human Pathology
    • 6.3.1 Human Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 6.4 Veterinary Pathology
    • 6.4.1 Veterinary Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 7 Digital Pathology Market: End-use Estimates & Trend Analysis

  • 7.1 Digital Pathology Market: End-Use Key Takeaways
  • 7.2 Digital Pathology Market: End-Use Movement Analysis
  • 7.3 Hospitals
    • 7.3.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.4 Biotechnology & Pharmaceutical Companies
    • 7.4.1 Biotechnology & Pharmaceutical Companies Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.5 Diagnostic Laboratories
    • 7.5.1 Diagnostic Laboratories Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
  • 7.6 Academic And Research Institutes
    • 7.6.1 Academic And Research Institutes Market Estimates And Forecasts, 2018 - 2030 (USD Billion)

Chapter 8 Digital Pathology Market: Regional Estimates & Trend Analysis, by Product, Application, End Use

  • 8.1 Digital Pathology Market: Region Movement Analysis
  • 8.2 Digital Pathology Market Shares by Region, 2023 & 2030
  • 8.3 North America
    • 8.3.1 North America Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.2 U.S.
      • 8.3.2.1 U.S. digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.3.3 Canada
      • 8.3.3.1 Canada digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.3.4 Mexico
      • 8.3.3.1 Canada digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.4 Europe
    • 8.4.1 Europe Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.3 UK
      • 8.4.3.1 UK digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.4 Germany
      • 8.4.4.1 Germany digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.5 France
      • 8.4.5.1 France digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.6 Italy
      • 8.4.6.1 Italy digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.7 Spain
      • 8.4.7.1 Spain digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.8 Russia
      • 8.4.8.1 Russia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.9 Netherlands
      • 8.4.9.1 Netherlands digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.10 Switzerland
      • 8.4.10.1 Switzerland digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.11 Sweden
      • 8.4.11.1 Sweden digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.12 Denmark
      • 8.4.12.1 Denmark digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.4.13 Norway
      • 8.4.13.1 Norway digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.2 Japan
      • 8.5.2.1 Japan digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.3 China
      • 8.5.3.1 China digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.4 India
      • 8.5.4.1 India digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.5 Indonesia
      • 8.5.5.1 Indonesia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.6 Thailand
      • 8.5.6.1 Thailand digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.7 Australia
      • 8.5.7.1 Australia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.8 South Korea
      • 8.5.8.1 South Korea digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.9 Philippines
      • 8.5.9.1 Philippines digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.11 Malaysia
      • 8.5.11.1 Malaysia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.5.12 Singapore
      • 8.5.12.1 Singapore digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
  • 8.6 Latin America
    • 8.6.1 Latin America Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.3 Brazil
      • 8.6.3.1 Brazil digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.6.4 Argentina
      • 8.6.4.1 Argentina digital pathology market estimates and forecasts, 2018- 2030 (USD Billion)
  • 8.7 MEA
    • 8.7.1 Mea Digital Pathology Market Estimates And Forecasts, 2018 - 2030 (USD Billion)
    • 8.7.2 South Africa
      • 8.7.2.1 South Africa digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.3 Saudi Arabia
      • 8.7.3.1 Saudi arabia digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.4 Turkey
      • 8.7.4.1 Turkey digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.5 Iran
      • 8.7.5.1 Iran digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.6 UAE
      • 8.7.6.1 UAE digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.7 Israel
      • 8.7.7.1 Israel digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)
    • 8.7.8 Kuwait
      • 8.7.8.1 Kuwait digital pathology market estimates and forecasts, 2018 - 2030 (USD Billion)

Chapter 9 Digital Pathology Market Competitive & Vendor Landscape

  • 9.1 Participation Categorization
  • 9.2 Vendor Landscape
    • 9.2.1 List Of Distributors
  • 9.3 Company Market Position Analysis
    • 9.3.1 Public Companies
    • 9.3.2 Private Companies
  • 9.4 Estimated Company Market Share Analysis, 2024 (%)
  • 9.5 Company Profiles
    • 9.5.1 Leica Biosystems Nussloch Gmbh (Danaher)
      • 9.5.1.1 Company overview
      • 9.5.1.2 Financial performance
      • 9.5.1.3 Product benchmarking
        • 9.5.1.3.1 Human DIgital Pathology
      • 9.5.1.4 Strategic initiatives
    • 9.5.2 HAMAMATSU PHOTONICS K.K.
      • 9.5.2.1 Company overview
      • 9.5.2.2 Financial performance
      • 9.5.2.3 Product benchmarking
        • 9.5.2.3.1 Human DIgital Pathology
      • 9.5.2.4 Strategic initiatives
    • 9.5.3 KONINKLIJKE PHILIPS N.V.
      • 9.5.3.1 Company overview
      • 9.5.3.2 Financial performance
      • 9.5.3.3 Product benchmarking
        • 9.5.3.3.1 Human DIgital Pathology
      • 9.5.3.4 Strategic initiatives
    • 9.5.4 OLYMPUS CORPORATION
      • 9.5.4.1 Company overview
      • 9.5.4.2 Financial performance
      • 9.5.4.3 Product benchmarking
        • 9.5.4.3.1 Human DIgital Pathology
      • 9.5.4.4 Strategic initiatives
      • 9.5.4.5 Company overview
      • 9.5.4.6 Financial performance
      • 9.5.4.7 Product benchmarking
        • 9.5.4.7.1 Human DIgital Pathology
      • 9.5.4.8 Strategic initiatives
    • 9.5.5 MIKROSCAN TECHNOLOGIES, INC.
      • 9.5.5.1 Company overview
      • 9.5.5.2 Financial performance
      • 9.5.5.3 Product benchmarking
        • 9.5.5.3.1 Human DIgital Pathology
      • 9.5.5.4 Strategic initiatives
    • 9.5.6 INSPIRATA, INC.
      • 9.5.6.1 Company overview
      • 9.5.6.2 Financial performance
      • 9.5.6.3 Product benchmarking
        • 9.5.6.3.1 Human DIgital Pathology
      • 9.5.6.4 Strategic initiatives
    • 9.5.7 VISIOPHARM A/S
      • 9.5.7.1 Company overview
      • 9.5.7.2 Financial performance
      • 9.5.7.3 Product benchmarking
        • 9.5.7.3.1 Human DIgital Pathology
      • 9.5.7.4 Strategic initiatives
    • 9.5.8 HURON TECHNOLOGIES INTERNATIONAL, INC.
      • 9.5.8.1 Company overview
      • 9.5.8.2 Financial performance
      • 9.5.8.3 Product benchmarking
        • 9.5.8.3.1 Human DIgital Pathology
      • 9.5.8.4 Strategic initiatives
    • 9.5.9 3DHISTECH LTD.
      • 9.5.9.1 Company overview
      • 9.5.9.2 Financial performance
      • 9.5.9.3 Product benchmarking
        • 9.5.9.3.1 Human DIgital Pathology
        • 9.5.9.3.2 Veterinary DIgital Pathology
      • 9.5.9.4 Strategic initiatives
    • 9.5.10 CONTEXTVISION AB
      • 9.5.10.1 Company overview
      • 9.5.10.2 Financial performance
      • 9.5.10.3 Product benchmarking
        • 9.5.10.3.1 Human DIgital Pathology
      • 9.5.10.4 Strategic initiatives
    • 9.5.11 SECTRA AB
      • 9.5.11.1 Company overview
      • 9.5.11.2 Financial Performance
      • 9.5.11.3 Product benchmarking
        • 9.5.11.3.1 Human DIgital Pathology
      • 9.5.11.4 Strategic initiatives
    • 9.5.12 AGFA-GEVAERT GROUP
      • 9.5.12.1 Company overview
      • 9.5.12.2 Financial Performance
      • 9.5.12.3 Product benchmarkin
        • 9.5.12.3.1 Human DIgital Pathology
      • 9.5.12.4 Strategic initiatives
    • 9.5.13 CELLAVISION
      • 9.5.13.1 Company overview
      • 9.5.13.2 Financial performance
      • 9.5.13.3 Product benchmarking
        • 9.5.13.3.1 Veterinary DIgital Pathology
      • 9.5.13.4 Strategic initiatives
    • 9.5.14 HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
      • 9.5.14.1 Company overview
      • 9.5.14.2 Financial performance
      • 9.5.14.3 Product benchmarking
        • 9.5.14.3.1 Human DIgital Pathology
    • 9.5.15 WEST MEDICA PRODUKTIONS- UND HANDELS- GMBH (WEST MEDICA)
      • 9.5.15.1 Company overview
      • 9.5.15.2 Financial performance
      • 9.5.15.3 Product benchmarking
        • 9.5.15.3.1 Human DIgital Pathology
        • 9.5.15.3.2 Veterinary DIgital Pathology
    • 9.5.16 AETHERAI
      • 9.5.16.1 Company overview
      • 9.5.16.2 Financial performance
      • 9.5.16.3 Product benchmarking
        • 9.5.16.3.1 Human DIgital Pathology
      • 9.5.16.4 Strategic initiatives
    • 9.5.17 IBEX (IBEX MEDICAL ANALYTICS)
      • 9.5.17.1 Company overview
      • 9.5.17.2 Financial performance
      • 9.5.17.3 Product benchmarking
        • 9.5.17.3.1 Human DIgital Pathology
      • 9.5.17.4 Strategic initiatives
    • 9.5.18 SIGTUPLE TECHNOLOGIES PRIVATE LIMITED
      • 9.5.18.1 Company overview
      • 9.5.18.2 Financial performance
      • 9.5.18.3 Product benchmarking
        • 9.5.18.3.1 Human DIgital Pathology
      • 9.5.18.4 Strategic initiatives
    • 9.5.19 MORPHLE LABS, INC
      • 9.5.19.1 Company overview
      • 9.5.19.2 Financial performance
      • 9.5.19.3 Product benchmarking
        • 9.5.19.3.1 Human DIgital Pathology
      • 9.5.19.4 Strategic initiatives
    • 9.5.20 BIONOVATION BIOTECH, INC
      • 9.5.20.1 Company overview
      • 9.5.20.2 Financial performance
      • 9.5.20.3 Product benchmarking
        • 9.5.20.3.1 Human DIgital Pathology
    • 9.5.21 SCOPIO LABS
      • 9.5.21.1 Company overview
      • 9.5.21.2 Financial performance
      • 9.5.21.3 Product benchmarking
        • 9.5.21.3.1 Veterinary DIgital Pathology
      • 9.5.21.4 Strategic initiatives
    • 9.5.22 PATH HUB US
      • 9.5.22.1 Company overview
      • 9.5.22.2 Product benchmarking
        • 9.5.22.2.1 Human Digital Pathology
        • 9.5.22.2.2 Veterinary Digital Pathology
    • 9.5.23. F. HOFFMANN-LA ROCHE LTD.
      • 9.5.23.1. Overview
      • 9.5.23.2. Financial Performance
      • 9.5.23.3. Product Benchmarking
      • 9.5.23.4. Strategic Initiatives
    • 9.5.24. Aiosyn
      • 9.5.24.1. Overview
      • 9.5.24.2. Financial Performance
      • 9.5.24.3. Product Benchmarking
      • 9.5.24.4. Strategic Initiatives
    • 9.5.25. Proscia Inc
      • 9.5.25.1. Overview
      • 9.5.25.2. Financial Performance
      • 9.5.25.3. Product Benchmarking
      • 9.5.25.4. Strategic Initiatives
    • 9.5.26. EVIDENT
      • 9.5.26.1. Overview
      • 9.5.26.2. Financial Performance
      • 9.5.26.3. Product Benchmarking
      • 9.5.26.4. Strategic Initiatives
    • 9.5.27. Aignostics, Inc.
      • 9.5.27.1. Overview
      • 9.5.27.2. Financial Performance
      • 9.5.27.3. Product Benchmarking
      • 9.5.27.4. Strategic Initiatives
    • 9.5.28. AIRA MATRIX
      • 9.5.28.1. Overview
      • 9.5.28.2. Financial Performance
      • 9.5.28.3. Product Benchmarking
      • 9.5.28.4. Strategic Initiatives
    • 9.5.29. Deep Bio Inc.
      • 9.5.29.1. Overview
      • 9.5.29.2. Financial Performance
      • 9.5.29.3. Product Benchmarking
      • 9.5.29.4. Strategic Initiatives
    • 9.5.30. Indica Labs, LLC
      • 9.5.30.1. Overview
      • 9.5.30.2. Financial Performance
      • 9.5.30.3. Product Benchmarking
      • 9.5.30.4. Strategic Initiatives
    • 9.5.31. Paige AI
      • 9.5.31.1. Overview
      • 9.5.31.2. Financial Performance
      • 9.5.31.3. Product Benchmarking
      • 9.5.31.4. Strategic Initiatives
    • 9.5.32. PathAI, Inc.
      • 9.5.32.1. Overview
      • 9.5.32.2. Financial Performance
      • 9.5.32.3. Product Benchmarking
      • 9.5.32.4. Strategic Initiatives
    • 9.5.33. Aiforia
      • 9.5.33.1. Overview
      • 9.5.33.2. Financial Performance
      • 9.5.33.3. Product Benchmarking
      • 9.5.33.4. Strategic Initiatives
    • 9.5.34. Dedalus S.p.A
      • 9.5.34.1. Overview
      • 9.5.34.2. Financial Performance
      • 9.5.34.3. Product Benchmarking
      • 9.5.34.4. Strategic Initiatives
    • 9.5.35. Qritive
      • 9.5.35.1. Overview
      • 9.5.35.2. Financial Performance
      • 9.5.35.3. Product Benchmarking
      • 9.5.35.4. Strategic Initiatives
    • 9.5.36. Mindpeak GmbH
      • 9.5.36.1. Overview
      • 9.5.36.2. Financial Performance
      • 9.5.36.3. Product Benchmarking
      • 9.5.36.4. Strategic Initiatives
    • 9.5.37. CGI Inc.
      • 9.5.37.1. Overview
      • 9.5.37.2. Financial Performance
      • 9.5.37.3. Product Benchmarking
      • 9.5.37.4. Strategic Initiatives
    • 9.5.38. Gestalt
      • 9.5.38.1. Overview
      • 9.5.38.2. Financial Performance
      • 9.5.38.3. Product Benchmarking
      • 9.5.38.4. Strategic Initiatives
    • 9.5.39 Epredia (3DHISTECH Ltd.)
      • 9.5.39.1. Overview
      • 9.5.39.2. Financial Performance
      • 9.5.39.3. Product Benchmarking
      • 9.5.39.4. Strategic Initiatives
f

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 North America Digital Pathology Market, By Country, 2018 - 2030 (USD Billion)
  • Table 4 North America Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 5 North America Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 6 North America Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 7 North America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 8 U.S. Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 9 U.S. Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 10 U.S. Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 11 U.S. Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 12 Canada Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 13 Canada Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 14 Canada Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 15 Canada Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 16 Mexico Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 17 Mexico Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 18 Mexico Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 19 Mexico Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 20 Europe Digital Pathology Market, By Country, 2018 - 2030 (USD Billion)
  • Table 21 Europe Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 22 Europe Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 23 Europe Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 24 Europe Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 25 UK Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 26 UK Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 27 UK Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 28 UK Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 29 Germany Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 30 Germany Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 31 Germany Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 32 Germany Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 33 France Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 34 France Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 35 France Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 36 France Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 37 Italy Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 38 Italy Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 39 Italy Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 40 Italy Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 41 Spain Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 42 Spain Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 43 Spain Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 44 Spain Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 45 Russia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 46 Russia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 47 Russia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 48 Russia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 49 Switzerland Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 50 Switzerland Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 51 Switzerland Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 52 Switzerland Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 53 Netherlands Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 54 Netherlands Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 55 Netherlands Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 56 Netherlands Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 57 Denmark Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 58 Denmark Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 59 Denmark Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 60 Denmark Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 61 Norway Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 62 Norway Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 63 Norway Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 64 Norway Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 65 Sweden Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 66 Sweden Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 67 Sweden Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 68 Sweden Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 69 Asia Pacific Digital Pathology Market, By Country, 2018 - 2030 (USD Billion)
  • Table 70 Asia Pacific Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 71 Asia Pacific Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 72 Asia Pacific Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 73 Asia Pacific Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 74 Japan Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 75 Japan Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 76 Japan Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 77 Japan Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 78 China Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 79 China Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 80 China Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 81 China Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 82 India Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 83 India Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 84 India Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 85 India Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 86 Indonesia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 87 Indonesia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 88 Indonesia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 89 Indonesia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 90 Thailand Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 91 Thailand Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 92 Thailand Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 93 Thailand Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 94 Australia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 95 Australia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 96 Australia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 97 Australia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 98 South Korea Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 99 South Korea Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 100 South Korea Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 101 South Korea Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 102 Philippines Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 103 Philippines Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 104 Philippines Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 105 Philippines Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 106 Malaysia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 107 Malaysia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 108 Malaysia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 109 Malaysia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 110 Singapore Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 111 Singapore Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 112 Singapore Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 113 Singapore Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 114 Latin America Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 115 Latin America Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 116 Latin America Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 117 Latin America Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 118 Brazil Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 119 Brazil Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 120 Brazil Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 121 Brazil Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 122 Argentina Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 123 Argentina Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 124 Argentina Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 125 Argentina Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 126 MEA Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 127 MEA Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 128 MEA Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 129 MEA Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 130 South Africa Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 131 South Africa Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 132 South Africa Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 133 South Africa Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 134 Saudi Arabia Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 135 Saudi Arabia Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 136 Saudi Arabia Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 137 Saudi Arabia Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 138 Turkey Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 139 Turkey Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 140 Turkey Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 141 Turkey Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 142 Iran Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 143 Iran Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 144 Iran Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 145 Iran Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 146 UAE Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 147 UAE Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 148 UAE Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 149 UAE Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 150 Israel Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 151 Israel Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 152 Israel Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 153 Israel Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)
  • Table 154 Kuwait Digital Pathology Market, By Product, 2018 - 2030 (USD Billion)
  • Table 155 Kuwait Digital Pathology Market, By Type, 2018 - 2030 (USD Billion)
  • Table 156 Kuwait Digital Pathology Market, By Application, 2018 - 2030 (USD Billion)
  • Table 157 Kuwait Digital Pathology Market, By End-Use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Digital pathology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Digital pathology market: Product movement analysis
  • Fig. 17 Digital pathology market: Product segment dashboard
  • Fig. 18 Digital pathology market product outlook: Key takeaways
  • Fig. 19 Software market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 20 Integrated Software market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 21 Standalone Software market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 22 Device market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 23 Storage system market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 24 Digital pathology market: Type movement analysis
  • Fig. 25 Digital pathology market: Type segment dashboard
  • Fig. 26 Digital pathology market type outlook: Key takeaways
  • Fig. 27 Human digital pathology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 28 Veterinary digital pathology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 29 Digital pathology market: Application movement analysis
  • Fig. 30 Digital pathology market: Application segment dashboard
  • Fig. 31 Digital pathology market application outlook: Key takeaways
  • Fig. 32 Drug discovery & development market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 33 Academic research market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 34 Disease diagnosis market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Digital pathology market: End-use movement analysis
  • Fig. 36 Digital pathology market: End-use segment dashboard
  • Fig. 37 Digital pathology market end-use outlook: Key takeaways
  • Fig. 38 Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 39 Biotech & pharma companies market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 40 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Academic &research institutes market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 Regional outlook, 2023 & 2030
  • Fig. 43 Regional market dashboard
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 North America, SWOT
  • Fig. 46 Europe, SWOT
  • Fig. 47 Asia Pacific, SWOT
  • Fig. 48 Latin America, SWOT
  • Fig. 49 Middle East and Africa, SWOT
  • Fig. 50 North America
  • Fig. 51 North America Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 52 U.S. Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 53 Canada Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 54 Mexico Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 55 Europe Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 56 UK Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 57 Germany Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 58 Spain Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 59 France Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 60 Italy Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 61 Russia Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 62 Ntherlands Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 63 Switzerland Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 64 Denmark Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 65 Norway Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 66 Sweden Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 67 Asia Pacific Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 68 Japan Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 69 China Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 70 India Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 71 South Korea Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 72 Australia Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 73 Thailand Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 74 Indonasia Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 75 South Korea Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 76 Philippines Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 77 Malaysia Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 78 Singapore Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 79 Latin America Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 80 Brazil Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 81 Argentina Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 82 MEA Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 83 South Africa Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 84 Saudi Arabia Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 85 Turkey Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 86 Iran Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 87 Italy Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 88 UAE Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 89 Isarel Digital pathology market, 2018 - 2030 (USD Billion)
  • Fig. 90 Kuwait Digital pathology market, 2018 - 2030 (USD Billion)